Revolution Medicines shares rise 6.47% premarket after Circio expands into Novum Labs facilities in Stockholm.

Revolution Medicines, Inc. rose 6.47% in premarket trading. The news event that aligns with this movement is the expansion of Circio into Novum Labs facilities in Stockholm. This expansion could be seen as a positive development for Revolution Medicines, Inc., as it indicates growth and potential for new partnerships or collaborations in the biotechnology sector.